These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3132724)

  • 1. Proto-oncogene fos expression and post-translational modification.
    Barber JR; Sassone-Corsi P; Verma IM
    Prog Clin Biol Res; 1988; 266():23-37. PubMed ID: 3132724
    [No Abstract]   [Full Text] [Related]  

  • 2. Proto-oncogene fos: factors affecting expression and covalent modification of the gene product.
    Barber JR; Sassone-Corsi P; Verma IM
    Ann N Y Acad Sci; 1987; 511():117-30. PubMed ID: 2830821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and viral fos genes: structure, regulation of expression and biological properties of their encoded products.
    Müller R
    Biochim Biophys Acta; 1986; 823(3):207-25. PubMed ID: 3011086
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncogene-mediated multistep transformation of C3H10T1/2 cells.
    Taparowsky EJ; Heaney ML; Parsons JT
    Cancer Res; 1987 Aug; 47(15):4125-9. PubMed ID: 3300959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the human dbl-oncogene and proto-oncogene products in insect cells using a baculovirus vector.
    Graziani G; Ron D; Srivastava S; Eva A
    Ann Ist Super Sanita; 1991; 27(1):115-21. PubMed ID: 1958019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V-sis gene (SSV) is expressed transiently and independently of v-gag (SSAV) after infection of fibroblasts with SSV/SSAV.
    Schätzl HM; von der Helm K
    Oncogene; 1989 Sep; 4(9):1095-101. PubMed ID: 2550873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum.
    Barber JR; Verma IM
    Mol Cell Biol; 1987 Jun; 7(6):2201-11. PubMed ID: 3110603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of protein-tyrosine kinases in cellular transformation.
    Varticovski L
    Sangre (Barc); 1991 Aug; 36(4):305-9. PubMed ID: 1663662
    [No Abstract]   [Full Text] [Related]  

  • 9. Different types of modification in c-fos and its associated protein p39: modulation of DNA binding by phosphorylation.
    Müller R; Bravo R; Müller D; Kurz C; Renz M
    Oncogene Res; 1987; 2(1):19-32. PubMed ID: 3146046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential.
    Ahmed NN; Franke TF; Bellacosa A; Datta K; Gonzalez-Portal ME; Taguchi T; Testa JR; Tsichlis PN
    Oncogene; 1993 Jul; 8(7):1957-63. PubMed ID: 8510938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell transformation by an oncogene that regulates protein kinases.
    Hanafusa H; Mayer BJ; Reichman C; Hamaguchi M
    Adv Second Messenger Phosphoprotein Res; 1990; 24():280-3. PubMed ID: 2169808
    [No Abstract]   [Full Text] [Related]  

  • 13. Deregulation and overexpression of c-fos proto-oncogene in rat renal cell-lines and primary tumors induced by dimethylnitrosamine.
    Shore SK; Hard GC; Magee PN
    Oncogene; 1988 Nov; 3(5):567-70. PubMed ID: 3152601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
    Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
    Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proto-oncogene fos: an inducible multifaceted gene.
    Mitchell RL; Hanks SK; Verma IM
    Symp Fundam Cancer Res; 1986; 39():99-113. PubMed ID: 2827284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure and function of the fos proto-oncogene.
    Cohen DR; Curran T
    Crit Rev Oncog; 1989; 1(1):65-88. PubMed ID: 2518683
    [No Abstract]   [Full Text] [Related]  

  • 18. Nuclear proto-oncogenes fos and jun.
    Ransone LJ; Verma IM
    Annu Rev Cell Biol; 1990; 6():539-57. PubMed ID: 2125830
    [No Abstract]   [Full Text] [Related]  

  • 19. Oncogenes and their mechanisms of action.
    Găldean D
    Roum Arch Microbiol Immunol; 1992; 51(1-2):75-99. PubMed ID: 1457825
    [No Abstract]   [Full Text] [Related]  

  • 20. [Negative control of expression of proto-oncogene c-fos promoter in undifferentiated cells of mouse teratocarcinoma F9].
    Kisliakova TV; Svetlikova SB; Lavrovskiĭ IaV; Pospelova TV; Pospelov VA
    Dokl Akad Nauk SSSR; 1990; 310(6):1504-6. PubMed ID: 2112993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.